Merck & Co., Inc. (SNSE:MRK)

Chile flag Chile · Delayed Price · Currency is CLP · Price in USD
102.40
0.00 (0.00%)
Last updated: Dec 16, 2025, 9:30 AM CLT
-20.50%
Market Cap227.78T
Revenue (ttm)61.77T
Net Income (ttm)18.30T
Shares Outn/a
EPS (ttm)7,265.86
PE Ratio12.44
Forward PE10.99
Dividend3,050.72 (2,979.22%)
Ex-Dividend DateDec 15, 2025
Volumen/a
Average Volume5
Open102.40
Previous Close102.40
Day's Range102.40 - 102.40
52-Week Range74.48 - 125.13
Beta0.39
RSI99.98
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Industry Drug Manufacturers - General
Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Santiago Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.